Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2001, p. 4160-4162, Vol. 39, No. 11
Division of Bacterial and Mycotic Diseases,
National Center for Infectious Diseases, Centers for Disease Control
and Prevention, Public Health Service, U.S. Department of Health and
Human Services, Atlanta, Georgia 30333
Received 20 April 2001/Returned for modification 16 July
2001/Accepted 15 August 2001
Ten strains of Lautropia mirabilis (ATCC
51599T and nine phenotypically similar clinical isolates)
were examined for cellular fatty acid (CFA) composition to evaluate
their chemical relatedness to known bacterial species and groups. The
CFAs were liberated from whole cells by base hydrolysis, methylated,
and analyzed by gas-liquid chromatography. CFA profiles were generated
by using a commerical software package (MIDI, Newark, Del.). All
strains tested had an identical CFA profile characterized by major
amounts of 16:1
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.11.4160-4162.2001
Cellular Fatty Acid Composition of
Lautropia mirabilis
7c (41%) and 16:0 (44%); smaller amounts (1 to 4%)
of 3-OH-10:0, 12:0, 14:0, 15:0, and 18:1
7c; trace amounts (<1%) of 10:0, 18:2 and 18:0; and no cyclopropane acids. This profile was
similar to the CFA profiles of Acidovorax delafieldii, Comamonas terrigena, and strains of an unclassified Centers for Disease Control group designated weak oxidizer group 1. CFA analysis, when
supplemented by phenotypic characterization, is useful for the
identification of L. mirabilis isolates.
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, 1600 Clifton Rd., N.E., Mailstop D11,
Atlanta, GA 30333. Phone: (404) 639-3861. Fax: (404) 639-4421. E-mail: mdaneshvar{at}cdc.gov.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|